Principal Financial Group Inc Clearside Biomedical, Inc. Transaction History

Principal Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.3 - $2.49 $58,984 - $112,978	-45,373 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$1.35 - $2.88 $26,960 - $57,516	-19,971 Reduced 30.56%	45,373 $104,000
Q4 2021 Feb 09, 2022	BUY	$2.72 - $5.72 $177,735 - $373,767	65,344 New	65,344 $180,000
Q4 2020 Feb 08, 2021	SELL	$1.32 - $2.74 $89,522 - $185,826	-67,820 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$1.45 - $2.0 $46,505 - $64,146	32,073 Added 89.72%	67,820 $104,000
Q2 2020 Aug 05, 2020	BUY	$1.55 - $2.41 $55,407 - $86,150	35,747 New	35,747 $67,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.